Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2008
06/26/2008WO2008077086A1 Aminopyrimidines useful as inhibitors of protein kinases
06/26/2008WO2008076225A2 Non-nucleoside reverse transcriptase inhibitors
06/26/2008WO2008076223A1 Non-nucleoside reverse transcriptase inhibitors
06/26/2008WO2008076041A1 Azetidinazabicyclo [3.2.1] octan derivatives that are neurokinin (nk) receptor antagonists and their use.
06/26/2008WO2008075353A1 Sulfonamide derivatives with therapeutic indications
06/26/2008WO2008075110A1 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
06/26/2008WO2008075109A1 Substituted piperidines having protein kinase inhibiting activity
06/26/2008WO2008075064A1 Piperidine derivatives for the treatment of obesity
06/26/2008WO2008075007A1 Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents
06/26/2008WO2008074966A1 Crth2 antagonists
06/26/2008WO2008074752A2 Indolylmaleimide derivatives as kinase inhibitors
06/26/2008WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents
06/26/2008WO2008047201A3 Solid dispersion comprising a poorly water soluble drug
06/26/2008WO2008043733B1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents
06/26/2008WO2008040820A3 Fungicidal n-heteroaryl-condensed pyridine derivatives and fungicidal compositions
06/26/2008WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives
06/26/2008WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors
06/26/2008WO2008021345A3 Process for the synthesis of 9-hydroxy risperidone (paliperidone)
06/26/2008WO2008011521A3 Polycyclic viral inhibitors
06/26/2008US20080154040 Azafluorene derivative and organic light-emitting device using the derivative
06/26/2008US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
06/26/2008US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease
06/26/2008US20080153863 Spiropiperidine derivatives
06/26/2008US20080153862 Vasopressin receptor (V1a) antagonists, treatment of anxiety and depressive disorders and other diseases
06/26/2008US20080153861 Vasopressin receptor (V1a) antagonists, treatment of anxiety and depressive disorders and other diseases
06/26/2008US20080153857 Specific capsaicin receptor modulators; analgesics; neuropathic pain; obesity; antitussives, hiccups; e.g. (4-Cyclopropyl-phenyl)-[2-methoxymethyl-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl]-amine
06/26/2008US20080153837 4-(Benzimidazol-2-yl)fluorene and 4-(azabenzimidazol-2-yl)fluorene derivatives; treating disorders related to Hsp90 protein; anticarcinogenic, antimetastasis, antitumor, anticoagulant, antiproliferative, antihistamine, and antidiabetic agents; metabolic, muscular, rheumatic and nervous system disorders
06/26/2008US20080153821 Nitrogen-containing 5-membered ring compound
06/26/2008US20080153812 Novel compounds
06/26/2008US20080153807 fused 1,2,4-triazoles for modulating the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions
06/26/2008CA2695613A1 Sulfonamide derivatives with therapeutic indications
06/26/2008CA2673356A1 Crth2 antagonists
06/26/2008CA2673353A1 Aminopyrimidines useful as inhibitors of protein kinases
06/26/2008CA2673093A1 Non-nucleoside reverse transcriptase inhibitors
06/26/2008CA2672898A1 Methods of neuroprotection by cyclin-dependent kinase inhibition
06/26/2008CA2672841A1 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
06/26/2008CA2672521A1 Pyrazole derivatives as protein kinase inhibitors
06/26/2008CA2671525A1 Indolylmaleimide derivatives
06/25/2008EP1935890A1 2-heteroaryl-substituted indole derivative
06/25/2008EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
06/25/2008EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues.
06/25/2008EP1934220A1 Inhibitors of the hiv integrase enzyme
06/25/2008EP1934219A1 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
06/25/2008EP1934218A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
06/25/2008EP1934217A1 New compounds ii
06/25/2008EP1934216A1 Naphthyridin derivatives
06/25/2008EP1934215A1 Isotopically substituted imidazopyridine derivatives for the treatment of gastrointestinal disorders
06/25/2008EP1934214A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
06/25/2008EP1934213A1 Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
06/25/2008EP1934181A2 Kinase inhibitors
06/25/2008EP1934176A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
06/25/2008EP1934174A1 Azetidines as mek inhibitors for the treatment of proliferative diseases
06/25/2008EP1933842A2 5-lipoxygenase-activating protein (flap) inhibitors
06/25/2008EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders
06/25/2008EP1678499B1 Chemical compound and assay
06/25/2008EP1675854B1 Imidazopyridine-derivatives as inductible no-synthase inhibitors
06/25/2008EP1670796B1 Imidazopyridine-derivatives as inducible no-synthase inhibitors
06/25/2008EP1606266A4 Chemical compounds
06/25/2008EP1560834B1 New tricyclic derivatives as ltd4 antagonists
06/25/2008EP1173180B1 Camptothecin analogs and methods of preparation thereof
06/25/2008EP0986382B1 Raf kinase inhibitors
06/25/2008CN101208352A Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
06/25/2008CN101208341A Hexarylene and pentarylene tetracarboxylic acid diimides
06/25/2008CN101208340A Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1
06/25/2008CN101208339A Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents
06/25/2008CN101208338A Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents
06/25/2008CN101208327A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
06/25/2008CN101208303A CGRP receptor antagonists
06/25/2008CN101208287A Method for production of substituted phenylmalonate esters novel phenylmalonate esters and use thereof
06/25/2008CN101205229A Dizotetracarboxylic dianiline compositions and preparation thereof
06/25/2008CN101205228A Method for synthesizing phosphodiesterase 5 inhibitor tadanafil
06/25/2008CN100396682C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
06/25/2008CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/25/2008CN100396675C Prodrugs of proton pump inhibitors
06/25/2008CN100396668C Non-imidazole aryloxypiperidines
06/24/2008US7390825 Process for the preparation of oxazolidinones and method of use thereof
06/24/2008US7390820 Substituted quinolinone derivatives and methods of use
06/24/2008US7390819 Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors
06/24/2008US7390818 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent
06/24/2008US7390815 Pyrazole compounds useful as protein kinase inhibitors
06/24/2008US7390811 Respiratory syncytial virus replication inhibitors
06/24/2008US7390801 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
06/24/2008US7390798 Carboxamide spirolactam CGRP receptor antagonists
06/19/2008WO2008073370A1 Aspartyl protease inhibitors containing a tricyclic ring system
06/19/2008WO2008073365A1 Aspartyl protease inhibitors
06/19/2008WO2008072596A1 Organic electroluminescent device, display and illuminating device
06/19/2008WO2008071918A1 Pyrido-pyrazine derivatives useful as herbicidal compounds
06/19/2008WO2008071765A1 Pharmaceutically active spiro-substituted benzimidazole derivatives
06/19/2008WO2008071646A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008WO2008071456A2 3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
06/19/2008WO2008071288A1 Indolizine derivatives and their use as antidiabetics
06/19/2008WO2008046982A3 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
06/19/2008WO2008044027A3 Pharmaceutical compounds having hsp90 inhibitory or modulating activity
06/19/2008WO2008031750A3 Process for the preparation of pyrido[2,1-a]isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine
06/19/2008WO2007058832A3 Pyrrolo (2, 3-b) pyridine derivatives useful as tec kinase inhibitors
06/19/2008US20080146806 Octahydropyrrolo[2,3C]Pyridine Derivatives and Pharmaceutical Use Thereof
06/19/2008US20080146800 method for resolving of zopiclone into its enantiomers (eszopiclone and (R)-zopiclone) and also provides a method of recycling of (R)-zopiclone
06/19/2008US20080146610 Isotopically substituted proton pump inhibitors
06/19/2008US20080146608 drugs such as 5-(6-Chloropyridazin-3-yl)-1-azabicyclo[3.2.1]octane, used for treatment or prevention of disorders related to a nicotinic receptor dysfunction
06/19/2008US20080146607 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents